Rigontec GmbH Appoints Dr. Christian Schetter as CEO
Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics…
5 February 2015 | By Rigontec GmbH
Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, announces the appointment of Dr. Christian Schetter as CEO...